Biochemistry

Special Issues

Following special issues within this section are currently open for submissions:

• Molecular and Immunological Approaches in Ophthalmology: Inflammatory Disorders (Deadline: 31 May 2022)
• Neuromelanin, Peripheral Melanin and Parkinson's Disease (Deadline: 31 May 2022)
• Frontiers in Chemical Tools for Targeted Cancer Therapy (Deadline: 31 May 2022)
• Neurotrophic Function of Phytochemicals for Neuroprotection in Aging and Neuropsychiatric Diseases (Deadline: 31 May 2022)
• miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics 2.0 (Deadline: 31 May 2022)
• Membrane Proteins: Structure, Function and Motion (Deadline: 31 May 2022)
• Gene Regulation and Cell Signaling in Endocrine and Metabolic Regulation (Deadline: 31 May 2022)
• Recent Advances of Neural Networks: From Molecular Mechanisms to Therapeutic Exploitation (Deadline: 31 May 2022)
• Designing Enzymes with Artificially Designed Properties: Genetic and Physicochemial Tools (Deadline: 31 May 2022)
• Carbonic Anhydrase and Biomarker Research 2021 (Deadline: 31 May 2022)
• Neurotransmitters and Neuropeptides in the Modulation of the Carotid Body 2.0 (Deadline: 31 May 2022)
• Biological Role of Oxidative Stress in Inflammatory Diseases (Deadline: 31 May 2022)
• Optic Neuropathies: Current and Future Strategies for Optic Nerve Protection and Repair (Deadline: 31 May 2022)
• Redox Modulation: Biological and Therapeutical Implication (Deadline: 31 May 2022)
• Proteomics and Its Applications in Disease (Deadline: 31 May 2022)
• Recent Developments in Ion Channel and Ion-Related Signaling (Deadline: 31 May 2022)
• Molecular Biomarkers of Selected Diseases of Civilization 2.0 (Deadline: 31 May 2022)
• Growth Hormone (GH): Multiple Therapeutic Possibilities and Molecular Mechanisms of Action 2.0 (Deadline: 31 May 2022)
• The Lesser Known World of RNA Circles (Deadline: 31 May 2022)
• Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology 2.0 (Deadline: 31 May 2022)
• Neuroprotection and Natural Compounds (Deadline: 31 May 2022)
• Protein and Nucleotide Engineering for Diagnoses and Biosensing (Deadline: 31 May 2022)
• Organic, Inorganic and Natural Molecules in Biomineralization (Deadline: 31 May 2022)
• Calcium Signaling in Human Health and Diseases 3.0 (Deadline: 20 June 2022)
• Structure and Function of Membrane Proteins 2.0 (Deadline: 25 June 2022)
• The Role of Stem Cells in Multiple Sclerosis (Deadline: 30 June 2022)
• Stem Cells from Dental Sources: Translational Applications in Medicine and Novel Approaches 2.0 (Deadline: 30 June 2022)
• Molecular Aspects of Degeneration and Regeneration in the Peripheral Nervous System (Deadline: 30 June 2022)
• Myeloperoxidase (Deadline: 30 June 2022)
• Molecular Mechanisms of Sjögren's Syndrome 2.0 (Deadline: 30 June 2022)
• Proteomics and Metabonomics for Personalised Medicine (Deadline: 30 June 2022)
• Membrane Trafficking in Proliferative Diseases (Deadline: 30 June 2022)
• Mitochondria and Cancer (Deadline: 30 June 2022)
• Flavonoids and Other Polyphenols in Health and Disease (Deadline: 30 June 2022)
• Mechanisms of Molecular Motor Triggered Cell Motility (Deadline: 30 June 2022)
• Novel Anti-inflammatory Molecules (Deadline: 30 June 2022)
• Computational Approaches for the Investigation of Complex Molecular Mechanisms (Deadline: 30 June 2022)
• Genetics of Lipids and Cardiovascular Disease (Deadline: 30 June 2022)
• New Generation Biomarkers in Kidney Transplantation (Deadline: 30 June 2022)
• New Insights into Inflammasomes (Deadline: 30 June 2022)
• Cellular and Molecular Mechanisms in Glomerulonephritis 2.0 (Deadline: 30 June 2022)
• Anthocyanins in Molecular Biology (Deadline: 30 June 2022)
• Roles of Sulfatases and Sulfotransferases in Fundamental Biological Processes (Deadline: 30 June 2022)
• mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging (Deadline: 30 June 2022)
• Synthetic Peptides and Peptidomimetics: From Basic Science to Biomedical Applications—2nd Edition (Deadline: 30 June 2022)
• Comprehensive Approach to Gastrointestinal Disorders (Deadline: 30 June 2022)
• Cell Fusion in the Living Matter (Deadline: 30 June 2022)
• Novel Insights into the Life Cycle of RNA Molecules (Deadline: 30 June 2022)
• Tumors of the Nervous System: New Insights into Signaling, Genetics and Therapeutic Targeting 2.0 (Deadline: 30 June 2022)
• Tissue Engineering and Cell Therapy (Deadline: 30 June 2022)
• Endoplasmic Reticulum Stress-Related Biomedical Implications (Deadline: 30 June 2022)
• Enzymes as Targets for Drug Development II (Deadline: 30 June 2022)
• NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways (Deadline: 30 June 2022)
• Extreme Biocatalysts: From Basic Research to Biotechnological Applications (Deadline: 30 June 2022)
• The Interplay of Oxidative Stress and Inflammation: From Mechanisms to Therapeutic Approaches (Deadline: 30 June 2022)
• Microbial Esterases: Genomics, Physiology, Structure, and Applications (Deadline: 30 June 2022)
• Signal Transduction 2.0: From Molecular Pathways to Translational Research (Deadline: 31 July 2022)
• Molecular Regulation of the Endomembrane System 2.0 (Deadline: 31 July 2022)
• Metal-Based Complexes in Cancer (Deadline: 31 July 2022)
• Emerging Roles of Microtubule-Associated Serine/Threonine (MAST) Kinases in Cell Biology and Biomedical Research (Deadline: 31 July 2022)
• Molecular Dynamics at Synapses (Deadline: 31 July 2022)
• Role of Redox Homeostasis and Oxidative Stress in Human Health (Deadline: 31 July 2022)
• Molecular and Cellular Mechanisms Underlying Taste, Smell and Beyond (Deadline: 31 July 2022)
• The Polymorphic World of G-Quadruplexes: From Structural Insights to Functional Activity 3.0 (Deadline: 31 July 2022)
• Role of Phosphodiesterase in Biology and Pathology 2.0 (Deadline: 31 July 2022)
• Mechanisms of Disease Progression and Drug Resistance in Myeloid Malignancies (Deadline: 31 July 2022)
• Ubiquitination in Health and Diseases: Volume II (Deadline: 31 July 2022)
• The Multifaceted S100B Protein: Physiological or Pathogenic Factor, Biomarker, Therapeutic Target (Deadline: 31 July 2022)
• MAPK in Health and Disease (Deadline: 31 July 2022)
• Sphingolipid Metabolism and Signaling in Diseases 2.0 (Deadline: 31 July 2022)
• Ligand Binding in Enzyme Systems 2.0 (Deadline: 31 July 2022)
• Involvement of the MAPK Pathway in Cancer and Immunology (Deadline: 31 July 2022)
• The Emerging Role of Calcium Signaling in Nervous System (Deadline: 31 July 2022)
• Sphingolipids: Signals and Disease 2.0 (Deadline: 31 July 2022)
• Surface Active Molecules in Bio-Medical Applications (Deadline: 31 July 2022)
• Advanced Researches on Matrix Metalloproteinases (MMPs) (Deadline: 31 July 2022)
• Metabolomics in Health and Disease (Deadline: 31 July 2022)
• New Molecular Designs for Drugs including Potential Antibiotics (Deadline: 31 July 2022)
• Novel Biomarkers and Therapeutic Targets for Melanoma (Deadline: 31 July 2022)
• Ubiquitin and Ubiquitin-Like Molecules in Cancer (Deadline: 31 July 2022)
• Ion Channels as Therapeutic Target: Drug Design and Pharmacological Investigation (Deadline: 31 July 2022)
• New Insights into the Epigenome and microRNAs in Musculoskeletal (Patho)physiology (Deadline: 31 July 2022)
• Multiple Enzyme Mechanism and Functions in Mitochondrial Biology (Deadline: 31 July 2022)
• Nuclear Genome Stability: DNA Replication and DNA Repair (Deadline: 31 July 2022)
• ERAD and Ubiquitination 2.0 (Deadline: 31 July 2022)
• Molecular Biology of Histamine Systems 2.0 (Deadline: 31 July 2022)
• Animal and Plant Cell–Tissue, Organ Specialization and Function: Investigational, Experimental and Medical Aspects 3.0 (Deadline: 31 July 2022)
• Molecular and Biological Mechanisms of Longevity (Deadline: 31 July 2022)
• Heme- and Hemoglobin Stress in Human Diseases 2.0 (Deadline: 31 July 2022)
• Implication of Ion Channels in Neurodevelopmental Disorders (Deadline: 31 July 2022)
• Recent Advances in Aquaporins (Deadline: 31 July 2022)
• Recent Advancements in Genome Editing Technologies and Their Applications for Cardiovascular Diseases (Deadline: 31 July 2022)
• Biocatalysis: An Eco-Friendly Scenario for the Manufacturing of APIs (Deadline: 11 August 2022)
• Extracellular Vesicles and Cell–Cell Communication 2.0 (Deadline: 30 August 2022)
• Calcium-Binding Proteins and Cell Signaling 3.0 (Deadline: 31 August 2022)
• Ubiquitination and Deubiquitination in Cellular Homeostasis (Deadline: 31 August 2022)
• Molecular Signaling Pathways in Brain Pathology (Deadline: 31 August 2022)
• DNA Damage Response, an Update (Deadline: 31 August 2022)
• Cellular and Molecular Biology in Autoimmune Disease (Deadline: 31 August 2022)
• Role of Stromal Cell Population in Myocardial Remodelling 2.0 (Deadline: 31 August 2022)
• Stem Cells-From Bench to Bedside 2022 (Deadline: 31 August 2022)
• Mitochondrial Disease and Therapy (Deadline: 31 August 2022)
• Liver–Gut Axis 2.0 (Deadline: 31 August 2022)
• Osteoclastogenesis and Osteogenesis 2.0 (Deadline: 31 August 2022)
• Nanotechnology for Drug Delivery (Deadline: 31 August 2022)
• Development and Function of the Reproductive System (Deadline: 31 August 2022)
• Digging into the Glial Cells: How Do They Affect Energy and Glucose Metabolism? (Deadline: 31 August 2022)
• The Trace Element Speciation in the Environmental, Food and Human Health Fields (Deadline: 31 August 2022)
• Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention (Deadline: 31 August 2022)
• Small Molecule Drug Design and Research (Deadline: 31 August 2022)
• Iron Metabolism and Inflammation (Deadline: 31 August 2022)
• MicroRNA Regulation of Autophagy and Their Role in Neurodegenerative Diseases (Deadline: 31 August 2022)
• Role of Soluble Beta Amyloid in the Depressive Disorders (Deadline: 31 August 2022)
• Mitochondrial Health and Small Organic Molecules/Natural Products (Deadline: 31 August 2022)
• Protein Biosynthesis and Drug Design & Delivery Processes (Deadline: 31 August 2022)
• The Molecules and Stem Cells in Bone Regeneration (Deadline: 25 September 2022)
• Tackling New and Reemerging Infectious Diseases through the Development of Novel Anti-infectives (Deadline: 26 September 2022)
• Nanoparticles and Other Nanostructures and the Control of Pathogens: From Bench to Vaccines (Deadline: 28 September 2022)
• Insulin Signaling and Fat Homeostasis in Metabolic and Neurodegenerative Disorders (Deadline: 29 September 2022)
• ABC Transporters: Where Are We 45 Years On? (Deadline: 30 September 2022)
• GPCR: Roles in Cell Development and Disease (Deadline: 30 September 2022)
• Hedgehog Signaling 3.0 (Deadline: 30 September 2022)
• Stress Signalling and Programmed Cell Death (Deadline: 30 September 2022)
• Yeast Cell Signalling Pathways (Deadline: 30 September 2022)
• Antiphospholipid Syndrome (Deadline: 30 September 2022)
• Current Topics in Trace Element and Mineral Research (Deadline: 30 September 2022)
• Huntingtin: Interacting Proteins, Degradation, Post-translational Modifications (Deadline: 30 September 2022)
• Nitric Oxide Synthases: Function and Regulation (Deadline: 30 September 2022)
• Notch Signaling in Skin Diseases (Deadline: 30 September 2022)
• The Na⁺/Ca²⁺ Exchanger Family: New Insights in Its Structure, Function, and Regulation (Deadline: 30 September 2022)
• Frontiers in Cell Death and Differentiation (Deadline: 30 September 2022)
• New Challenges in Human & Animal Vaccines (Deadline: 30 September 2022)
• Molecular Mechanisms of Ion Transport across Cell Membranes (Deadline: 30 September 2022)
• Electron Microscopy for Hydrophilic Specimen and Related Measurements (Deadline: 30 September 2022)
• Chemistry towards Biology (Deadline: 30 September 2022)
• Modifications of Protein Termini 2.0 (Deadline: 30 September 2022)
• Novel Osteogenic Molecules and Delivery Methods for Bone Regeneration (Deadline: 30 September 2022)
• Molecular Mechanisms of Steroid Hormone Biosynthesis and Action (Deadline: 30 September 2022)
• Role of the 2-Oxo Acid Dehydrogenase Complexes in Metabolism: Genetics, Structure and Function (Deadline: 30 September 2022)
• Overcoming Brain Barriers (Deadline: 30 September 2022)
• Modulation of Protein Structure and Function by Lipids (Deadline: 30 September 2022)
• Mitochondrial Bioenergetics in Different Pathophysiological Conditions 3.0 (Deadline: 30 September 2022)
• Mitochondrial Biogenesis and Metabolism in Gastrointestinal System Pathophysiology (Deadline: 30 September 2022)
• Evolution and Function of the Hsp70 and Hsp90 Chaperone Machineries 2.0 (Deadline: 1 October 2022)
• Molecular Mechanisms of Retinal Degeneration and How to Avoid It (Deadline: 1 October 2022)
• Amyloids and Neurological Diseases (Deadline: 15 October 2022)
• Metabolism and the Biological Functions of Oxylipins (Deadline: 15 October 2022)
• Gut Hormone: Molecular Mechanism and Its Biological Functions (Deadline: 15 October 2022)
• Lysophosphatidic Acid Signaling in Anti-tumor Immune Response (Deadline: 16 October 2022)
• Intracellular Logistics and Organelle Dynamics (Deadline: 20 October 2022)
• Protein and Nucleotide Engineering for Diagnoses and Biosensing II (Deadline: 20 October 2022)
• Advances in Antibody Design and Antigenic Peptide Targeting 2.0 (Deadline: 20 October 2022)
• New Molecular Mechanisms and Markers in Inflammatory Disorders (Deadline: 25 October 2022)
• Advanced Glycation End Products (AGEs) and Their Receptor RAGE (Deadline: 25 October 2022)
• Small Molecules with Spiro-Conjugated Cycles: Advances in Synthesis and Applications (Deadline: 30 October 2022)
• The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles 2.0 (Deadline: 31 October 2022)
• Incretin-Mimetics/GLP-1 Analogs/SGLT-2 Inhibitors: From Basic Science to Pre-clinical Practice (Deadline: 31 October 2022)
• PPARs as Key Mediators of Metabolic and Inflammatory Regulation—2nd Edition (Deadline: 31 October 2022)
• Signaling Transduction in Cancer Metabolism (Deadline: 31 October 2022)
• State of the Art of Brain-Derived Neurotrophic Factor (Deadline: 31 October 2022)
• The Multiple and Dynamic Faces of Protein Structure: Folded States, Intrinsically Unfolded States, and Aggregates/Fibrils (Deadline: 31 October 2022)
• Autophagy in Health, Aging and Disease 3.0 (Deadline: 31 October 2022)
• Biotechnological Applications of Oxidoreductases (Deadline: 31 October 2022)
• Cellular Crosstalk in the Tumor Microenvironment (Deadline: 31 October 2022)
• Sensing, Mechanistic, and Functional Roles of TRP Channels in Ocular Tissues (Deadline: 31 October 2022)
• Bilirubin (Deadline: 31 October 2022)
• Redox Modulation by Antioxidants, Seen through the Energy Perspective (Deadline: 31 October 2022)
• Cancer Targeted Small Molecules (Deadline: 31 October 2022)
• Natural, Designed and Engineered Metalloenzymes: Structure, Catalytic Mechanisms and Applications (Deadline: 31 October 2022)
• Impact of Exposome on Dry Eye Disease (Deadline: 31 October 2022)
• Molecular Mechanisms Underlying Stress Response and Resilience 2.0 (Deadline: 31 October 2022)
• Cancer Cell Plasticity for Reprogramming-from Mechanisms to Therapies (Deadline: 31 October 2022)
• Modes of Action of Polyamine Metabolism (Deadline: 31 October 2022)
• New Advancement in Membrane Transport Proteins (Deadline: 31 October 2022)
• Role of Ectonucleotidases in Health and Disease (Deadline: 31 October 2022)
• Insights into the Molecular Regulation of Ion Transporters in Chronic Kidney Disease (Deadline: 10 November 2022)
• Molecular Mechanisms of mRNA Transcriptional Regulation (Deadline: 15 November 2022)
• Regulation of Estrogen Metabolism in Obesity (Deadline: 15 November 2022)
• Protein Folding and Misfolding — Structure and Functions 2.0 (Deadline: 15 November 2022)
• Theranostic Ultrasound Contrast Agents in Medical Applications (Deadline: 20 November 2022)
• Molecular Mechanisms of Toxic and Activated Effects of Exogenous Compounds (Deadline: 20 November 2022)
• Glutamine: An Essential Non-essential Amino Acid 2.0 (Deadline: 30 November 2022)
• High Density Lipoprotein and Cardiovascular Well Being (Deadline: 30 November 2022)
• Quality of HDL and LDL: Metabolism, Nutrition, Exercise and Health Impact (Deadline: 30 November 2022)
• Mitochondrial Function in Health and Disease 2022 (Deadline: 30 November 2022)
• Metal-Organic and Organometallic Compounds Targeting Intracellular Components Inducing Apoptosis (Deadline: 30 November 2022)
• Atherosclerosis and Other Related-Arterial Diseases (Deadline: 30 November 2022)
• Calcium Channels and Calcium-Binding Proteins (Deadline: 30 November 2022)
• Recent Developments on Protein–Ligand Interactions: From Structure, Function to Applications 2.0 (Deadline: 30 November 2022)
• Calcium Homeostasis in Skeletal Muscle Function, Plasticity and Disease (Deadline: 30 November 2022)
• Zinc-Finger Proteins in Health and Disease 2.0 (Deadline: 10 December 2022)
• Drug Discovery and Novel Platelet Signaling in Thrombogenesis (Deadline: 31 December 2022)
• Calcium Channel Regulation in Cancer: Unravelling the Molecular Mechanisms beneath the Membrane (Deadline: 31 December 2022)
• Lipids: From the Structure, Function and Evolution to Applications (Deadline: 31 December 2022)
• Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors (Deadline: 31 December 2022)
• Lipid Signaling and Metabolism in Inflammation-Associated Diseases (Deadline: 31 December 2022)
• Aquaporins: Dynamic Role and Regulations (Deadline: 31 December 2022)
• Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity 2.0 (Deadline: 31 December 2022)
• Cytochromes P450: Drug Metabolism, Bioactivation and Biodiversity 4.0 (Deadline: 31 December 2022)
• Insights into Park7 (DJ-1), a Multifunctional Protein Links to Parkinson Disease (Deadline: 31 December 2022)
• Cell Metabolism and Small Natural Compounds (Deadline: 31 January 2023)
• Effects of Irradiation on the Cardiovascular System: New Insights into Molecular Mechanism (Deadline: 31 January 2023)
• Biochemistry, Molecular Biology and Druggability of Proteins (Deadline: 28 February 2023)
• Molecular Interactions and Mechanisms of COVID-19 Inhibition 2.0 (Deadline: 15 March 2023)
• Mesenchymal Stem/Progenitor Cells and Their Derivates in Tissue Regeneration - Part II (Deadline: 31 March 2023)
• Complex Carbohydrates and Glycoconjugates: Structure, Functions and Applications 2022 (Deadline: 31 May 2023)

Topical Collections

Following topical collections within this section are currently open for submissions:

• 21st Anniversary of IJMS: Advances in Biochemistry
• Advances in Proteomic Research
• Antifungal Compounds
• Biocatalysis and Bioengineering
• Carbonic Anhydrase and Carbonic Anhydrase Inhibitors
• Feature Paper Collection in Biochemistry
• G Protein-Coupled Receptor Signaling and Regulation
• Protein Folding
• Proteins and Protein-Ligand Interactions
• Recent Advances in Molecular Research of Metabolic Disorders
• State-of-the-Art Biochemistry in Germany
• State-of-the-Art Biochemistry in Italy
• State-of-the-Art Biochemistry in Japan
• State-of-the-Art Biochemistry in Korea
• State-of-the-Art Biochemistry in Poland
• State-of-the-Art Biochemistry in Russia
• State-of-the-Art Biochemistry in Spain
• State-of-the-Art Biochemistry in UK
• State-of-the-Art Biochemistry in USA